BridgeMD
New treatment option for Type 1 Diabetes Mellitus
Official title The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions
ClinicalTrials.gov ID: NCT07145671
What this study is testing
- What it's testing
- A study is undertaken to examine the feasibility of the newly developed transition program in adolescents with type 1 diabetes, asthma and obesity in a multicentric setting. Specific objectives for this study are: (1) examining the impact of the program in terms of patient-reported health outcomes, (2) examining patients' and healthcare providers' experiences related to the program implementation process, and (3) examining the impact of the program in terms of cost-effectiveness.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 21. Healthy volunteers may be eligible.
You may be able to join if
- For participants in the intervention group (IG):
- 17 years old;
- diagnosed with type 1 diabetes, asthma and/or obesity;
- who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months;
- are Dutch speaking;
You likely can't join if
- Applicable for both CG and IG:
- \- patients with severe mental, cognitive or neurological problems will be excluded
See the full eligibility criteria
- For participants in the intervention group (IG):
- 17 years old;
- diagnosed with type 1 diabetes, asthma and/or obesity;
- who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months;
- are Dutch speaking;
- planned to transfer to adult care within the next 12 months. For participants in the control group (CG):
- age 17,5 and 18 years old, as the control period has a shorter duration (4 months vs. 12 months)
- diagnosed with type 1 diabetes, asthma and/or obesity;
- who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months;
- are Dutch speaking;
- planned to transfer to adult care within the next 12 months.
- Applicable for both CG and IG:
- \- patients with severe mental, cognitive or neurological problems will be excluded
The study team makes the final eligibility decision.
Where it's taking place
- Ghent, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 21 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ghent, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.